Chronic Viral Hepatitis: Current Management and Future Directions

The past decade has seen transformation in the strategies for identifying and managing viral hepatitis, most dramatically the transformation of hepatitis C virus from a mostly chronic affliction to a curable disease that is accessible to wide populations through direct‐acting antiviral therapies. Mo...

Full description

Bibliographic Details
Main Authors: Albert Do, Nancy S. Reau
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.1480
id doaj-5a54f3699af147e48e5e903b9db41683
record_format Article
spelling doaj-5a54f3699af147e48e5e903b9db416832020-11-25T02:23:34ZengWileyHepatology Communications2471-254X2020-03-014332934110.1002/hep4.1480Chronic Viral Hepatitis: Current Management and Future DirectionsAlbert Do0Nancy S. Reau1Section of Digestive Diseases Department of Internal Medicine Yale School of Medicine New Haven CTSection of Hepatology Rush University Medical Center Chicago ILThe past decade has seen transformation in the strategies for identifying and managing viral hepatitis, most dramatically the transformation of hepatitis C virus from a mostly chronic affliction to a curable disease that is accessible to wide populations through direct‐acting antiviral therapies. More recently, shifting of hepatitis C virus burden to younger patients driven by intravenous drug use has shaped screening recommendations. Future work focusing on effective screening, linkage to care, treatment initiation, and post‐cure management will allow countries to work toward meeting goals of eliminating viral hepatitis as a major public health threat. Concurrently, hepatitis B virus has also seen advances in management using oral nucleos(t)ide therapies with high‐resistance barriers. However, virologic cure remains elusive in the setting of viral genetic persistence within the hepatocyte nucleus, even with suppressive antiviral therapy. Future directions include a refined definition of “cure,” new biomarkers, and development of therapies targeting multiple pathways in the viral pathogenic and replication pathway. Progress is additionally being made on the management of hepatitis D infection. This review summarizes the recent evolution in disease characteristics, associated affected population, and changes in our understanding of management for these infections. We also discuss future directions in the management of viral hepatitis, including discussion on issues related to management before and after antiviral therapy. Conclusion: We summarize recent advances in the identification and management of viral hepatitis, which hold the potential to markedly reduce disease burden and therefore associated liver‐related complications. However further work is needed to adequately identify and manage these diseases.https://doi.org/10.1002/hep4.1480
collection DOAJ
language English
format Article
sources DOAJ
author Albert Do
Nancy S. Reau
spellingShingle Albert Do
Nancy S. Reau
Chronic Viral Hepatitis: Current Management and Future Directions
Hepatology Communications
author_facet Albert Do
Nancy S. Reau
author_sort Albert Do
title Chronic Viral Hepatitis: Current Management and Future Directions
title_short Chronic Viral Hepatitis: Current Management and Future Directions
title_full Chronic Viral Hepatitis: Current Management and Future Directions
title_fullStr Chronic Viral Hepatitis: Current Management and Future Directions
title_full_unstemmed Chronic Viral Hepatitis: Current Management and Future Directions
title_sort chronic viral hepatitis: current management and future directions
publisher Wiley
series Hepatology Communications
issn 2471-254X
publishDate 2020-03-01
description The past decade has seen transformation in the strategies for identifying and managing viral hepatitis, most dramatically the transformation of hepatitis C virus from a mostly chronic affliction to a curable disease that is accessible to wide populations through direct‐acting antiviral therapies. More recently, shifting of hepatitis C virus burden to younger patients driven by intravenous drug use has shaped screening recommendations. Future work focusing on effective screening, linkage to care, treatment initiation, and post‐cure management will allow countries to work toward meeting goals of eliminating viral hepatitis as a major public health threat. Concurrently, hepatitis B virus has also seen advances in management using oral nucleos(t)ide therapies with high‐resistance barriers. However, virologic cure remains elusive in the setting of viral genetic persistence within the hepatocyte nucleus, even with suppressive antiviral therapy. Future directions include a refined definition of “cure,” new biomarkers, and development of therapies targeting multiple pathways in the viral pathogenic and replication pathway. Progress is additionally being made on the management of hepatitis D infection. This review summarizes the recent evolution in disease characteristics, associated affected population, and changes in our understanding of management for these infections. We also discuss future directions in the management of viral hepatitis, including discussion on issues related to management before and after antiviral therapy. Conclusion: We summarize recent advances in the identification and management of viral hepatitis, which hold the potential to markedly reduce disease burden and therefore associated liver‐related complications. However further work is needed to adequately identify and manage these diseases.
url https://doi.org/10.1002/hep4.1480
work_keys_str_mv AT albertdo chronicviralhepatitiscurrentmanagementandfuturedirections
AT nancysreau chronicviralhepatitiscurrentmanagementandfuturedirections
_version_ 1724858726954827776